NUVL CLUSTER SEC Filing Analysis

Latest settled — T+20d

NUVL ▲ +5.40% at T+20d

SHORT call ✗ call lost -5.40% · α vs SPY +7.20% · entry $96.72 → $101.94

Next anchor: T+60d in 14d

Currently $123.25 · -27.43% from $96.72 entry (call sign-flipped)

Entry anchored
Mar 27, 03:59 PM ET
via Databento tick

T+1d

+5.92%

call -5.92% · α -3.03%

$102.45

settled 2mo ago

T+5d

+5.72%

call -5.72% · α -1.42%

$102.25

settled 2mo ago

T+20d

+5.40%

call -5.40% · α +7.20%

$101.94

settled 6w ago

T+60d

—

call — · α —

—

in 14d

Price Chart

Loading chart...

Executive Summary

Nuvalent CEO and CFO sold shares worth $1.79M in a coordinated cluster over the past week, with the CEO selling $1.17M and exercising options worth $259K. The transactions represent a material insider selling event involving top leadership.

Key Financial Metrics

Direction

selling

Total Value

$1.8M

Insiders

3

Actionable Insight

Traders should watch for potential downward pressure on NUVL shares, particularly given the CEO's large sale immediately following option exercises. This pattern may signal lack of confidence in near-term upside, especially in a high-growth biotech where executives typically hold long-term equity. Monitor upcoming earnings or pipeline updates for catalysts that could justify or counter this selling.

Key Facts

CEO James Richard Porter sold 11,354 shares for $1.17M and exercised 27,428 derivative shares (two tranches of 13,714) at $18.93, realizing $259,606 in value.
CFO Alexandra Balcom sold 3,500 shares for $370,365.
Chief Development Officer Darlene Noci sold 2,500 shares for $247,000.
Total open-market sales: $1.79M over a 7-day window, representing ~0.022% of $8.0B market cap.
All three transactions were reported under Form 4 with code 'S' (open-market sale).

Financial Impact

$1.79M in net insider selling over 7 days

insider ownershipmarket sentimentshareholder dilution perception

Risk Factors

Insider selling concentrated among C-suite executives, including CEO and CFO, increasing signal strength.
Risk of negative market perception around equity monetization after stock run-up, potentially dampening investor sentiment.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-NUVL-1775680253361

11 reports for NUVL

T+1T+5T+20T+60

40% Hit rate 2 of 5 directional calls best @ T+1▲ +2.73%Apr 7, 2026

Filters

Reports for NUVL — sortable, filterable
	Type				Now
Jun 9, 2026 today	8-K BULLISH ★ 8/10	$122.90 awaiting T+20	awaiting T+20	—	$123.25 (+0.29%)
May 7, 2026 4w ago	8-K NEUTRAL ★ 4/10	$102.40 $90.18	▼ −11.93%	▼ −15.07%	$123.25 (+20.36%)
Apr 29, 2026 6w ago	Insider Cluster NEUTRAL ★ 2/10	$99.10 $107.38	▲ +8.36%	▲ +2.90%	$123.25 (+24.37%)
Apr 7, 2026 9w ago	8-K BULLISH ★ 7/10	$102.25 $102.62	▲ +0.36%	▼ −9.42%	$123.25 (+20.54%)
Apr 6, 2026 9w ago	Insider Cluster BEARISH ★ 6/10	$103.71 $102.62	▲ +1.05%	▲ +10.03%	$123.25 (−18.84%)
Mar 30, 2026 10w ago	Insider Cluster BEARISH ★ 7/10	$96.72 $101.94	▼ −5.40%	▲ +7.20%	$123.25 (−27.43%)
Mar 26, 2026 10w ago	Insider Cluster NEUTRAL ★ 3/10	$98.06 $104.50	▲ +6.57%	▼ −4.10%	$123.25 (+25.69%)
Mar 25, 2026 11w ago	Insider Cluster BEARISH ★ 7/10	$98.00 $108.02	▼ −10.22%	▼ −2.36%	$123.25 (−25.77%)
Mar 25, 2026 11w ago	Insider Cluster BEARISH ★ 6/10	$98.00 $100.49	▼ −2.54%	▲ +5.32%	$123.25 (−25.77%)
Mar 6, 2026 13w ago	Insider Cluster NEUTRAL ★ 4/10	$99.41 $103.71	▲ +4.33%	▲ +6.37%	$123.25 (+23.98%)

US Market Status

Market Closed — Opens Thu (9h 38m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access